SCHEMBL13899485

SCHEMBL13899485

Cc1nn(-c2ccccc2)nc1COc1ccc(C=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
CYP3A4 P08684 2/20 0.45
MPO P05164 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 7/20 0.43
TSHR P16473 1/20 0.40
NR1H4 Q96RI1 1/20 0.39
SCN9A Q15858 1/20 0.39
PKM P14618 3/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
KAT2B Q92831 1/20 0.39
PPARG P37231 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13899500 0.88 PPARG (0.48) KDM4EALDH1A1SMN1; SMN2CYP3A4LMNA
SCHEMBL13899336 0.86 MAOA (0.54) KDM4ECYP3A4MPORAB9ALMNA
SCHEMBL13899537 0.86 LMNA (0.43) KDM4EALDH1A1SMN1; SMN2CYP3A4MPO
SCHEMBL13906078 0.78 LMNA (0.47) KDM4EALDH1A1SMN1; SMN2CYP3A4MPO
SCHEMBL13140182 0.76 CMKLR1 (0.48) KDM4EALDH1A1CYP3A4MPOLMNA
SCHEMBL13899484 0.76 LMNA (0.48) KDM4EALDH1A1SMN1; SMN2CYP3A4MPO
SCHEMBL3978471 0.76 MAPT (0.42) KDM4EALDH1A1CYP3A4MPOLMNA
SCHEMBL13899355 0.75 PPARG (0.47) KDM4ECYP3A4MPORAB9ALMNA
SCHEMBL4640180 0.74 MPO (0.55) KDM4EALDH1A1CYP3A4MPOMEN1
SCHEMBL24701303 0.74 CYP3A4 (0.48) KDM4EALDH1A1SMN1; SMN2CYP3A4MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507757-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-03-24 US disclosed
US-7507757-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-03-24 US disclosed